Angiotensin II does not acutely regulate conduction velocity in rat atrial tissue

References

• Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376–80.
   PubMed Web of Science ®Google Scholar
• Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003;107:2926–31.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005;45:712–9.
   PubMed Web of Science ®Google Scholar
• Schneider MP, Hua TA, Böhm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by renin-angiotensin system inhibition: a meta-analysis. J Am Coll Cardiol 2010;55:2299–307.
   PubMed Web of Science ®Google Scholar
• Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802–9.
   PubMed Web of Science ®Google Scholar
• De Mello WC, Altieri P. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 1992;20:643–51.
   PubMed Web of Science ®Google Scholar
• De Mello WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension 1996;27:1267–72.
   PubMed Web of Science ®Google Scholar
• Hofgaard JP, Banach K, Mollerup S, Jorgensen HK, Olesen SP, Holstein-Rathlou NH, Nielsen MS. Phosphatidylinositol-bisphosphate regulates intercellular coupling in cardiac myocytes. Pflugers Arch 2008;457:303–13.
   PubMed Web of Science ®Google Scholar
• Hussain WAJI, Patel PM, Chowdhury RA, Cabo CAND, Ciaccio EJ, Lab MJ, Duffy HS, Wit AL, Peters NS. The renin-angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle. J Cardiovasc Electrophysiol 2010;21:1276–83.
   PubMed Web of Science ®Google Scholar
• Hadrup N, Petersen JS, Praetorius J, Meier E, Graebe M, Brond L, Staahltoft D, Nielsen S, Christensen S, Kapusta DR, Jonassen TE. Opioid receptor-like 1 stimulation in the collecting duct induces aquaresis through vasopressin-independent aquaporin-2 downregulation. Am J Physiol Renal Physiol 2004;287:F160–8.
   Web of Science ®Google Scholar
• Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK, Nielsen MS. The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol 2005;16:537–45.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 1999;10:1361–75.
   PubMed Web of Science ®Google Scholar
• Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 2001;51:681–90.
   PubMed Web of Science ®Google Scholar
• van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, de Bakker JM. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 2004;109: 1048–55.
   PubMed Web of Science ®Google Scholar
• Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, Gutstein DE. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004;95:1035–41.
   PubMed Web of Science ®Google Scholar
• Chen SA, Chang MS, Chiang BN, Cheng KK, Lin CI. Electromechanical effects of angiotensin in human atrial tissues. J Mol Cell Cardiol 1991;23:483–93.
   PubMed Web of Science ®Google Scholar
• Feolde E, Vigne P, Frelin C. Angiotensin II receptor subtypes and biological responses in the rat heart. J Mol Cell Cardiol 1993;25:1359–67.
   PubMed Web of Science ®Google Scholar
• Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 1993;88:1228–37.
   PubMed Web of Science ®Google Scholar
• Bauer P, Regitz-Zagrosek V, Hofmeister J, Lokies J, Rolfs A, Hildebrandt AG, Hetzer R, Fleck E. Reduced atrial angiotensin receptor type 1 mRNA content in end-stage human heart failure: assessment by a novel quantitative PCR-ELISA technique. J Mol Med 1996;74:447–54.
   PubMed Web of Science ®Google Scholar
• Lenz O, Schmid B, Kilter H, La RK, Flesch M, Kuhn-Regnier F, Sudkamp M, Bohm M. Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium. Eur J Pharmacol 1995;294:17–27.
   PubMed Web of Science ®Google Scholar
• Mollmann H, Schmidt-Schweda S, Nef H, Mollmann S, Burstin JV, Klose S, Elsasser A, Holubarsch CJ. Contractile effects of angiotensin and endothelin in failing and non-failing human hearts. Int J Cardiol 2007;114:34–40.
   PubMed Web of Science ®Google Scholar
• Baker KM, Singer HA. Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 1988;62:896–904.
   PubMed Web of Science ®Google Scholar
• Lefroy DC, Crake T, Del MF, Vescovo G, Dalla LL, Harding S, Poole-Wilson PA. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol 1996;270:H2060–9.
   Google Scholar
• Leite-Moreira AF, Castro-Chaves P, Pimentel-Nunes P, Lima-Carneiro A, Guerra MS, Soares JB, Ferreira-Martins J. Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect. Br J Pharmacol 2006;147:690–7.
   PubMed Web of Science ®Google Scholar
• Lemarié CA, Schiffrin EL. The angiotensin II type 2 receptor in cardiovascular disease. J Renin-Angiotensin-Aldosterone Syst 2010;11:19–31.
   PubMed Web of Science ®Google Scholar
• Korte T, Fuchs M, Guener Z, Bonin J, de SM, Niehaus M, Tebbenjohanns J, Drexler H. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J Interv Card Electrophysiol 2002;6:121–32.
   PubMed Web of Science ®Google Scholar
• Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72: 69–79.
   PubMed Web of Science ®Google Scholar
• Rosiak M, Ruta J, Bolinska H. Usefulness of prolonged P-wave duration on signal averaged ECG in predicting atrial fibrillation in acute myocardial infarction patients. Med Sci Monit 2003;9:MT85–8.
   PubMedGoogle Scholar